The clinical applications of PET go beyond breast, lung, colorectal, lymphoma and skin cancers. A PET scan
has the unique ability to provide a picture of the organs at work, showing the metabolic activity of the organs. This helps physicians
diagnosis cancer, detect if the cancer has spread, look for signs of recurrent cancer and evaluate treatment. PET is a proven tool
in these additional oncological applications:
Initial diagnosis
Determine if cancer has spread
Detect recurrent/residual tumor following therapy
Initial diagnosis
Determine if the cancer has spread
Detect recurrent/residual tumor following therapy
Detect recurrent/residual tumor prior to surgical exploration or additional chemotherapy
Differentiate brain tumor from radiation necrosis
Exclude metastatic disease to the brain
Evaluate local extent of disease and exclude distant metastasis
Measure treatment response and exclude recurrent/residual tumor following definitive therapy
Detect recurrent/residual tumor after definitive
initial treatment
*PET imaging assists physicians in the characterization of cancers. The cancer listings do not suggest
that the PET imaging procedure is covered by either private insurance payers or Medicare. Please check with your insurance
company to confirm payment authorization.
|
